Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR

NCT00879307 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

BIPOLAR DISORDER

Interventions

DRUG: quetiapine

Sponsor

Hospital de Clinicas de Porto Alegre